POSTER PRESENTATION
Adherence and persistence
to preventive migraine treatments over 12 months follow-up for patients with migraine: calcitonin gene-related peptide monoclonal antibodies versus other preventive treatments
Total pain burden in patients
with previous failure of 2-4 migraine preventive medication categories: effects of galcanezumab in the CONQUER Phase 3b Trial
Annual indirect cost
savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials
Functional REstoration with
rEyvow (FREE): a US-based cross-sectional survey in patients taking lasmiditan